-
Democrats, Trump hold final rallies before midterm elections
-
African players in Europe: Defender Hakimi's historic hat-trick
-
Japan urges US to enforce discipline after second Marine arrest
-
Struggling Slavia face Arsenal as grim record looms
-
'Remarkable' rookie Lendeborg scores 37 as Warriors beat Clippers
-
Vikings suffer first loss while Broncos edge Chiefs in NFL
-
ExxonMobil urged to re-think Papua New Guinea gas project
-
South Korea to double spending on AI and chips in 2027
-
Asian stocks mixed as tech sector struggles to rebound from selloff
-
On All Saints' Day, Philippine mountain town honours dead with fire
-
India's royals find new power in their past
-
Years on from fall of IS, French jihadists face justice in Iraq
-
Irish bookshops help meet UK demand for Sally Rooney novels
-
Point of Law favourite at Australia's 'race that stops a nation'
-
NFL Vikings suffer first loss while Broncos edge Chiefs
-
'Kid' Antonelli gets affectionate tributes from all quarters
-
Host of fresh faces in Australia white-ball squads to face England
-
Hamilton accuses Leclerc of wrecking Ferrari hopes
-
NFL linebacker Campbell to remain hospitalized overnight
-
enVVeno Medical to Showcase the enVVe System at 38th Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium
-
Gladstone Alternative Income Fund Announces Monthly Cash Distribution for November 2026
-
Nexscient Announces Expanded Customer Engagements and New Commercial Agreements in Autonomous Driving and Humanoid Robotics Data Services
-
Vicapsys Life Sciences Provides Shareholder Update on VICAPSYN(TM) Program Advancing Toward Phase 1 Human Clinical Trial, Vertically Integrated With the Company's Indian Health Service Strategy
-
XCF Global Withdraws Reverse Stock Split Proposal; Reaffirms Growth Strategy and Shareholder Support
-
Gladstone Commercial Corporation Earnings Call and Webcast Information
-
cbdMD Completes Acquisition of the Operating Assets and Brands of Twinlab, including Twinlab, Reserveage and Metabolife Brands, Expanding Into Broader Wellness
-
Palo Alto Collaboration Company Opens Waitlist for Pana, a Personal AI That Builds Tools That Stay Yours
-
Anthony, Linder & Cacomanolis Recognized in Chambers & Partners Spotlight Florida 2027 for Securities Law Excellence
-
Tectonic Metals Intersects 5.61 g/t Au Over 41.15 m, Including 12.94 g/t Au Over 13.72 m, Within 2.86 g/t Au Over 91.44 m, Strengthening Evidence for a Second Gold System at the Flat Gold Project
-
IRS Pushes Tax Deadlines to February 1, 2027 for Washington Wildfire Counties - Clear Start Tax Explains What the Postponement Does Not Pause
-
Optimistivity Unveils Refreshed Brand and Expanded Digital Product Range
-
GameSquare to Report Q3 2026 Financial Results on November 16, 2026
-
AsiaFIN Holdings Corp. to Host Q3 2026 Earnings Webcast from New York City
-
Predictiv AI Awarded Metrolinx Master Agreement for On-Demand Transit Software and Related Services
-
Electric Metals (USA) Limited Announces Results of Annual Meeting of Stockholders
-
iAsk.ai Surpasses One Billion Searches
-
International Battery Metals Announces Second Quarter Fiscal 2027 Financial Results Conference Call and Webcast
-
Electrovaya Ranks Fourth Among Canada's Enterprise - Industry Leaders in Deloitte's Technology Fast 50(TM) Program
-
BEING rather than HAVING. A fascinating, practical STORY.
-
Hospital AI Funding Faces a Reality Check: New 2027 Outlook Puts Outsourcing Savings to the Test
-
Jaguar Mining Provides Update on Permitting of the Onças de Pitangui Development Project, Minas Gerais, Brazil
-
Ur-Energy Announces Retirement of CFO Roger Smith, Names VP Finance Jade Walle as Successor
-
DataMEDS AI Enters Into Agreement for Commercial Supply of Six Peptides Recommended by FDA Advisory Committee
-
Aer Lingus and MTech Mobility Launch Live Ground Operations Technology Programme Across Three Irish Airports
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 02
-
Medical Care Technologies Inc. (OTCID:MDCE) Delivers Stronger Melanoma Scan Beta Readout on Expanded Human-Submitted Dataset
-
With Expansion into Naval Shipbuilding, Hanwha Philly Shipyard Names 25-Year Shipbuilding Veteran as President
-
ASGA's Attack on Menhaden Science Exposes Its Own Double Standard
-
Family Hospice Care Celebrates 20 Years of Light, Love and Legacy During National Home Health Month and Hospice and Palliative Care Month
-
Hop-on (OTCID: HPNN) Subsidiary Digitalage Completes Core Cre-ator Platform Build, Moves to Enterprise Technology Licensing
Omicron starts receding in the United States: data
The United States appears to be emerging from its latest coronavirus wave driven by the Omicron variant, data showed Wednesday, though cases remain far higher than during any previous surge and Covid hospitalizations are at a peak.
The fast to rise, fast to fall graph could follow the same pattern seen in other countries hit by the highly-mutated strain, including South Africa, Britain and France.
A seven-day-average of new daily cases peaked at around 795,000 on January 13, an official tracker maintained by the Centers for Disease Control and Prevention (CDC) showed.
Though figures over the weekend and public holidays, such as Monday, January 17, are impacted by lower reporting rates and should be treated with caution, numbers were already falling by Friday.
"We hope to close the books on this winter surge soon," New York Governor Kathy Hochul said Tuesday.
The declines were most pronounced in states that were hit first by the wave, particularly in the northeast, including New York, New Jersey and Maryland.
On the other hand, cases were still rising fast in parts of the west, including New Mexico, Arizona and Utah.
Though Omicron is milder in most people compared to the previously dominant Delta strain, hospitalizations remain at a high of just under 160,000 people, partly because of the sheer number of people impacted, and partly because of coincidental infections.
The figure appears to be flat and would be expected to start falling soon.
As to what happens next in the pandemic, many experts, including top US infectious disease scientist Anthony Fauci, are hopeful the virus may continue evolving into a more prevalent but less severe pathogen because of selection pressure.
This would mean eventually living with a virus that causes only mild-to-moderate disease in most vaccinated people, with treatments such as Pfizer's antiviral pill and monoclonal antibody infusions to help people who are at highest risk.
There are, however, no guarantees. In a recent interview with Der Spiegel, Fauci said that there would be continuing "smoldering" infections, particularly in lower-income countries with lower vaccination rates.
"It is conceivable that the next variant will have a high degree of transmissibility but also a high degree of severity," he said.
D.Kaufman--AMWN